Neural Biomarkers of Clozapine Response
Sponsor: University of Pittsburgh
Listed as NCT03076346, this observational or N/A phase trial focuses on Schizoaffective Disorder and Schizophrenia and remains completed. Sponsored by University of Pittsburgh, it has been updated 13 times since 2017, reflecting substantial change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
13 versions recorded-
Apr 2025 — Present [monthly]
Completed
-
Sep 2024 — Apr 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Feb 2021 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Jan 2021 — Feb 2021 [monthly]
Recruiting
▶ Show 8 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Recruiting
-
Sep 2019 — Sep 2020 [monthly]
Recruiting
-
Oct 2018 — Sep 2019 [monthly]
Recruiting
-
Jun 2018 — Oct 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Recruiting NA
Status: Enrolling By Invitation → Recruiting
-
Jul 2017 — Oct 2017 [monthly]
Enrolling By Invitation NA
Status: Not Yet Recruiting → Enrolling By Invitation
-
Apr 2017 — Jul 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Pittsburgh
For direct contact, visit the study record on ClinicalTrials.gov .